CONEX- dexbrompheniramine maleate, pseudoephedrine liquid

Conex by

Drug Labeling and Warnings

Conex by is a Otc medication manufactured, distributed, or labeled by Llorens Pharmaceutical International Division. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]


Trademark Results [Conex]

Mark Image

Registration | Serial
Company
Trademark
Application Date
CONEX
CONEX
90038190 not registered Live/Pending
Trilogy Networks Inc
2020-07-06
CONEX
CONEX
88210793 5787638 Live/Registered
CV Technology, Inc.
2018-11-29
CONEX
CONEX
87564850 not registered Dead/Abandoned
Aziyo Med, LLC
2017-08-11
CONEX
CONEX
86373655 4806849 Live/Registered
American Maplan Corporation
2014-08-21
CONEX
CONEX
85690105 not registered Dead/Abandoned
Pharmaceutical Generic Developers Inc. USA
2012-07-30
CONEX
CONEX
85542294 not registered Dead/Abandoned
Advanced Expos LLC
2012-02-14
CONEX
CONEX
85126705 4107494 Live/Registered
CONEX UNIVERSAL LIMITED
2010-09-10
CONEX
CONEX
79159108 4910798 Live/Registered
Conex IPR Limited
2014-11-14
CONEX
CONEX
78187847 2831935 Live/Registered
THE EUCLID CHEMICAL COMPANY
2002-11-22
CONEX
CONEX
76402597 2683447 Dead/Cancelled
Norwolf Tool Works
2002-04-29
CONEX
CONEX
76313726 2707843 Dead/Cancelled
CONEX, L.L.C.
2001-09-19
CONEX
CONEX
76156217 not registered Dead/Abandoned
Key Productions, Inc.
2000-10-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.